Steven Collis, CEO of drug distributor AmerisourceBergen, made $14.7 million in his company's 2019 fiscal year based on the actual realized gains on his stock, according to new company disclosures.

The big picture: That amount was down from the $18.7 million Collis earned in 2018.

  • But it's still above industry average and comes as the company is mired in thousands of lawsuits that allege it contributed to the opioid epidemic by not properly monitoring the flow of painkillers.

The big picture: AmerisourceBergen distributed 13 billion opioid pills throughout the country from 2006 through 2014, according to the Washington Post — a fact that has put AmerisourceBergen and other distributors in court.

By the numbers: A $1.9 million cash bonus was included within Collis' total. That bonus was based solely on three adjusted financial metrics and did not factor in quality or the opioid litigation.

  • An AmerisourceBergen spokesperson did not respond to questions about whether the bonuses were appropriate given the company's legal troubles, but said in a statement the company's compensation structure does "not incentivize unnecessary risk-taking."

Go deeper:

Go deeper

1 hour ago - Sports

Pac-12 will play football this fall, reversing course

A view of Levi's Stadium during the 2019 Pac-12 Championship football game. Photo: Alika Jenner/Getty Images

The Pac-12, which includes universities in Arizona, California, Colorado, Oregon, Utah and Washington state, will play football starting Nov. 6, reversing its earlier decision to postpone the season because of the coronavirus pandemic.

Why it matters: The conference's about-face follows a similar move by the Big Ten last week and comes as President Trump has publicly pressured sports to resume despite the ongoing pandemic. The Pac-12 will play a seven-game conference football season, according to ESPN.

Dave Lawler, author of World
2 hours ago - World

Global coronavirus vaccine initiative launches without U.S. or China

Data: Gavi, The Vaccine Alliance; Map: Naema Ahmed/Axios

A global initiative to ensure equitable distribution of coronavirus vaccines now includes most of the world — but not the U.S., China or Russia.

Why it matters: Assuming one or more vaccines ultimately gain approval, there will be a period of months or even years in which supply lags far behind global demand. The COVAX initiative is an attempt to ensure doses go where they're most needed, rather than simply to countries that can produce or buy them at scale.

Updated 3 hours ago - Politics & Policy

Coronavirus dashboard

Illustration: Sarah Grillo/Axios

  1. Global: Total confirmed cases as of 6:15 p.m. EST: 32,062,182 — Total deaths: 979,701 — Total recoveries: 22,057,268Map.
  2. U.S.: Total confirmed cases as of 6:15 p.m EST: 6,967,103 — Total deaths: 202,558 — Total recoveries: 2,670,256 — Total tests: 97,459,742Map.
  3. Health: Cases are surging again in 22 states — New York will conduct its own review of coronavirus vaccine.
  4. Business: America is closing out its strongest quarter of economic growth.
  5. Technology: 2020 tech solutions may be sapping our resolve to beat the pandemic.
  6. Sports: Here's what college basketball will look like this season.
  7. Science: During COVID-19 shutdown, a common sparrow changed its song.

Get Axios AM in your inbox

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Please enter a valid email.

Subscription failed
Thank you for subscribing!